Research And Development Expense Non Proliferative Diabetic Retinopathy Treatment

Name: Ocular Therapeutix Research And Development Expense Non Proliferative Diabetic Retinopathy Treatment by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Ocular Therapeutix·Business Segments·1 segment

Breakdown

Segment	FY'25
Business Segments	$4.8M
Total	$4.8M

All segment values are derived from annual filings.

Segments

Business SegmentsView metric